From the Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL.
Department of Radiation Oncology, Mayo Clinic, Rochester, MN.
Pancreas. 2020 Jul;49(6):737-743. doi: 10.1097/MPA.0000000000001566.
Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness, which increase the cell kill while potentially reducing toxicities to nearby normal tissues. Although small, early clinical studies have shown promise in both the resectable and unresectable settings to improve local control and overall survival while minimizing toxicities. Currently, there are several trials, including 2 sponsored by institutions in the United States, investigating the role of carbon ion radiotherapy for the treatment of locally advanced pancreatic cancer.
胰腺癌是全球第四大常见的癌症相关死亡原因,尽管采用了积极的治疗方法,但其预后仍然不佳。碳离子放疗在治疗中有良好的放射生物学和物理特性,包括更高的线性能量转移和更高的相对生物学效应,这增加了细胞杀伤的同时,潜在地降低了对附近正常组织的毒性。尽管规模较小,但早期的临床研究表明,碳离子放疗在可切除和不可切除的情况下都有希望改善局部控制和总体生存率,同时最大限度地减少毒性。目前,有几项试验,包括由美国机构赞助的 2 项试验,正在研究碳离子放疗在治疗局部晚期胰腺癌中的作用。